Clariane SELTS:0OPS -3.09%61 OCF Yield % is 70.94 as of Jun. 30, 2026, which is 165% above its 10-year median of 26.72. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Clariane SE ranks better than 98.54% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clariane SE's OCF Yield % or its related term are showing as below:
LTS:0OPS'
s OCF Yield % Range Over the Past 10 Years
Min: 9.37 Med: 26.72 Max: 509.26
Current: 70.94
During the past 13 years, the highest OCF Yield % of Clariane SE was 509.26%. The lowest was 9.37%. And the median was 26.72%.
LTS:0OPS's OCF Yield % is ranked better than 98.54% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.51
vs LTS:0OPS: 70.94
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clariane SE OCF Yield % Related Terms
Clariane SE OCF Yield % Historical Data
* Premium members only.
The historical data trend for Clariane SE's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Clariane SE's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Clariane SE's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (LTS:0OPS) has a OCF Yield % of 70.94 as of Jun. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clariane SE and its competitors. This is 165% above median its historical median of 26.72. Over the past decade, Clariane SE's OCF Yield % has ranged from 9.37 to 509.26. According to the industry distribution chart, Clariane SE ranks #10 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 1.5%.
Is Clariane SE's OCF Yield % too high?
Clariane SE's current OCF Yield % of 70.94 is 165% above median its 10-year median of 26.72. Over the past 10 years, this metric has ranged from a low of 9.37 to a high of 509.26. The Healthcare Providers & Services industry median OCF Yield % is 5.51. Clariane SE's value of 70.94 is 1187.5% above this industry median. Based on the distribution chart, Clariane SE ranks #10 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #10 out of 683 companies for OCF Yield %. This places Clariane SE in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.51. Clariane SE's value of 70.94 is 1187.5% above this benchmark. Historically, Clariane SE's own OCF Yield % has ranged from 9.37 to 509.26 over the past decade. While the company's 10-year median is 26.72 vs. the industry median of 5.51, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.51, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current OCF Yield % of 70.94 is 1187.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current OCF Yield % is 70.94, which is 165% above median its own 10-year median of 26.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current OCF Yield % is 70.94, which is 165% above median its 10-year median of 26.72 and 1187.5% above the Healthcare Providers & Services industry median of 5.51. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current OCF Yield % is 70.94 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (LTS:0OPS) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for LTS:0OPS:
OCF Yield %: 70.94 (165% above median its 10-year median of 26.72)
GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
Industry Position: 1187.5% above the Healthcare Providers & Services median (#10 of 683)
No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for LTS:0OPS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OPS has been successfully added to your 
